Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of this study was to assess physician and patient satisfaction with ofatumumab using data collected from physicians and their multiple sclerosis (MS) patients in real-world clinical practice across the United Kingdom (UK), France, Germany, Italy, Spain, China, Japan, and Brazil.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| MS Patient Cohort | Adult patients diagnosed with relapsing multiple sclerosis (RMS) who received treatment with ofatumumab, and were invited to participate following a consult with their physician. |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Number and Percentage of Patients by Patient-reported Level of Satisfaction With Current MS Treatment | Patient's level of satisfaction with current treatment categorized as follows:
| 1 Day |
| Number and Percentage of Patients by Patient-reported MS Status With Their Current Medication Compared to Previous Medication | MS status, as reported by the patient, categorized as follows:
| 1 Day |
| Number and Percentage of Patients by Physician-reported Patient Response to Current MS Treatment | How well the patient is responding to current treatment rated by the physician from 1 (very poorly) to 5 (very well). | 1 Day |
| Number and Percentage of Patients by Physician-reported Level of Satisfaction With the Patient's Current MS Treatment | Physician's level of satisfaction with patient's current treatment categorized as follows:
| 1 Day |
| Number and Percentage of Patients Adherent to Current MS Treatment as Reported by the Physician | Adherence, as reported by the physician, categorized as follows:
| 1 Day |
| Measure | Description | Time Frame |
|---|---|---|
| Number and Percentage of Patients by Factors That Influence How the Patient Rates Current Medication Compared to Previous Medication | Factors influencing how patients rate medication include:
|
Not provided
Physician inclusion criteria:
Patient inclusion criteria:
Patients for whom physicians complete a Physician Completed Patient Record Form (PRF), and therefore are included in the pool of data for analysis, are based on the following criteria:
Exclusion criteria:
• None
Not provided
Not provided
Physicians that treat with ofatumumab and MS patients receiving ofatumumab, and who were invited to participate following consultation with their physician.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Novartis Pharmaceuticals | Novartis Pharmaceuticals | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Novartis | Basel | CH-4056 | Switzerland |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D009103 | Multiple Sclerosis |
| D010549 | Personal Satisfaction |
| D017060 | Patient Satisfaction |
| ID | Term |
|---|---|
| D020278 | Demyelinating Autoimmune Diseases, CNS |
| D020274 | Autoimmune Diseases of the Nervous System |
| D009422 | Nervous System Diseases |
| D003711 | Demyelinating Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| Number and Percentage of Patients by Physician-reported Change in Patient Condition Since Initiation of Current MS Treatment | Change in condition, as reported by the physician, categorized as follows:
| 1 Day |
| 1 Day |
| Number and Percentage of Patients by Physician-reported Reason for Current MS Treatment Choice | 1 Day |
| Number and Percentage of Patients by Physician-reported Top 5 Reasons for Current MS Treatment Choice | 1 Day |
| Number and Percentage of Patients by Physician-reported Main Areas of Improvement for the Patient's Current MS Treatment | 1 Day |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |
| D001519 | Behavior |
| D000074822 | Treatment Adherence and Compliance |
| D015438 | Health Behavior |